Adoptive immunotherapy with recombinant human IL-2 (rHuIL-2) after autologous stem cell transplantation (ASCT) for high-risk neuroblastoma (HR-NB).

被引：0
|
作者：
Pession, A
Prete, A
Locatelli, F
Alvisi, P
Garaventa, A
Messina, C
Pierinelli, S
Bonetti, F
Cordero, L
Favre, C
Arrighini, A
Rondelli, R
DeBernandi, B
Paolucci, G
机构：
[1] DEPT PEDIAT,PAVIA,ITALY
[2] DEPT PEDIAT,TURIN,ITALY
[3] DEPT PEDIAT,PADUA,ITALY
[4] DEPT PEDIAT,PISA,ITALY
[5] DEPT PEDIAT,BRESCIA,ITALY
[6] DEPT PEDIAT,GENOA,ITALY
来源：
EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：374 / 374
页数：1
相关论文
共 50 条
  • [21] Autologous stem cell transplantation (ASCT) for multiple myeloma followed by immunomodulation with interferon-2α (IFN-2α) and interleukin-2 (IL-2).
    Oliveira, JSR
    Cecyn, KZ
    Faria, RMD
    Parisio, K
    Ribeiro, APMR
    Gomes, LS
    Juliane, JMF
    Raineri, G
    BLOOD, 2001, 98 (11) : 397B - 397B
  • [22] The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies
    Mora, Jaume
    Castaneda, Alicia
    Flores, Miguel A.
    Santa-Maria, Vicente
    Garraus, Moira
    Gorostegui, Maite
    Simao, Margarida
    Perez-Jaume, Sara
    Mane, Salvador
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [23] Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation
    Peinemann, Frank
    van Dalen, Elvira C.
    Enk, Heike
    Tytgat, Godelieve A. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (04):
  • [24] Interleukin-2 (IL-2) post high dose chemotherapy mobilized autologous stem cell transplant (ASCT) for hematologic malignancies.
    Oliveira, JSR
    Cecyn, KZ
    Parisio, K
    Faria, JR
    Ribeiro, MSS
    Chauffaille, MDLF
    Raineri, G
    BLOOD, 2001, 98 (11) : 396B - 397B
  • [25] TREATMENT-RELATED TOXICITY OF ANTI-GD2 ANTIBODY IMMUNOTHERAPY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN HIGH-RISK NEUROBLASTOMA PATIENTS
    Kataoka, Shinsuke
    Yamamori, Ayako
    Imaya, Masayuki
    Wakamatsu, Manabu
    Narita, Kotaro
    Taniguchi, Rieko
    Narita, Atsushi
    Muramatsu, Hideki
    Nishio, Nobuhiro
    Takahashi, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [26] Autologous stem cell transplants (ASCT) cultured in interleukin-2 (IL-2) for high risk acute myelogenous leukemia (AML) in first complete remission (CR).
    Hogge, D
    Eaves, C
    Barnett, M
    Conneally, E
    Nantel, S
    Nevill, T
    Shepherd, J
    Sutherland, H
    Toze, C
    Klingemann, H
    BLOOD, 1998, 92 (10) : 292A - 292A
  • [27] The role of autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy: Results of 2 consecutive studies in a single referral institution.
    Mora, Jaume
    Castaneda, Alicia
    Angel Flores, Miguel
    Santa-Maria, Vicente
    Garraus, Moira
    Gorostegui, Maite
    Simao, Margarida
    Perez-Jaume, Sara
    Mane, Salvador
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based Immunotherapy
    Cicek, Filiz
    Troschke-Meurer, Sascha
    Ceylan, Kiraz
    Jahns, Luciana J.
    Zumpe, Maxi
    Siebert, Nikolai
    Ehlert, Karoline
    Lode, Holger N.
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [29] Survival of children with high-risk neuroblastoma after conventional treatment followed by high-dose chemotherapy and autologous stem cell transplantation
    Caldas, G
    Lacerda, AF
    Neto, A
    Vieira, E
    Pereira, F
    Ribeiro, MJ
    Chagas, M
    Ambrosio, A
    Miranda, N
    Leal-da-Costa, F
    Passos-Coelho, JL
    Abecasis, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S225 - S225
  • [30] EFFECTS OF INVIVO ADMINISTRATION OF HUMAN RECOMBINANT IL-2 TO CYNOMOLGUS MONKEYS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    KEEVER, CA
    GILLIO, AP
    LEVICK, J
    BONILLA, MA
    OREILLY, RJ
    WELTE, K
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (06) : 157 - 161
12345